Health & Biotech
Check out the latest Biotech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Rare opportunities – ASX health stocks tackling unmet medical needs
Health & Biotech
Health Check: Vitura Health swoops on medical dope telehealth platform
Health & Biotech
ASX healthcare leaders wear many hats in interconnected sector
Health & Biotech
Biocurious: Hut Hut Hut! The growing list of ASX biotechs waiting for the FDA to call the start of play
Health & Biotech
Health Check: CSL’s blood business saves the day amid declining flu jab rates
Tech
Four ASX stocks seeking a competitive edge in the lucrative sports market
Health & Biotech
Dr Boreham’s Crucible: On a dream run, this biotech shows no sign of dozing on the job
Health & Biotech
Health Check: Ansell gloves up for Trump tariff threat
Health & Biotech
Scott Power: ASX health stocks drop as Trump’s proposed tariffs rattle global markets
Health & Biotech
Health Check: Percheron ‘closes the book’ on failed childhood rare disease program
Health & Biotech
Biocurious: Consumer health minnow Wellnex Life gears up for company-making Eurotrip
Health & Biotech
Health Check: Ahead of Chemist Warehouse merger, brokers ring bell on ‘overvalued’ Sigma shares
Health & Biotech
ASX January Health Winners: Artrya and EBR among the leaders in strong month
Health & Biotech
Biocurious: EBR Systems is on a ‘glide path’ to FDA approval for its novel heart device
Health & Biotech
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
Health & Biotech
Dr Boreham’s Crucible: FDA approval blasted this regenerative biotech higher in 2024… so what’s next?
News
ASX January winners: ASX reached record high but February off to a rocky start
Health & Biotech
Health Check: Fisher & Paykel Healthcare shares tumble after Trump tariff king-hit
Health & Biotech
ASX Quarterly Health Wrap: Blinklab starts key FDA study, Mach 7 set to meet FY25 guidance
Stockhead TV
Tony’s Takeaway: Replicating rewards
Health & Biotech
ASX Quarterly Health Wrap: Bioxyne revenue up 77%, Radiopharm lists on Nasdaq
Health & Biotech
Health Check: Alterity angles for fast-track FDA approval after positive trial results tackling Parkinson’s-like disorder
Health & Biotech
Broker Upgrades: Canaccord says disease specialist Opthea could triple if Phase III trial passes muster
Health & Biotech
Phase III Trials: It’s crunch time for these ASX health stocks
Health Check: With a US military win, Bio-Gene declares germ warfare on mosquitos, ticks and bed bugs
Health & Biotech
Biocurious: Lung imager Cyclopharm is breathing easy in the US market
News
Closing Bell: ASX flat as Chinese AI DeepSeek spooks markets
Health & Biotech
Health Check: The urge to merge is spurring a global biotech recovery
Health & Biotech
The ASX biotechs aiming to catch cancer early
Health & Biotech
Scott Power: Cardiac pacing device developer EBR hits Morgans price target amid ‘rotation back into healthcare’
Health & Biotech
Cardiex launches app, begins US Deliveries of flagship CONNEQT Pulse
Health & Biotech
Health Check: From feather duster to rooster, Nanosonics again rules the roost
Health & Biotech
Health Check: We’ll see you in court and you bladder believe it, says Pacific Edge after unfavourable US ruling
Health & Biotech
Biocurious: EZZ’s tennis sponsorship serves up 300 million Chinese viewers
Health & Biotech
Health tech Thrive Tribe serves up a new star chief exec
Health & Biotech
Recce Pharmaceuticals doses all patients in phase II skin infection trial
Health & Biotech
Health Check: Did the earth move for you? The world shifts on its axis as it enters the Trump era mark two
Health & Biotech
Dr Boreham’s Crucible: Radiopharm hopes to turn up the sweet sound of success
Health & Biotech
Health Check: Investor hearts pump as EBR girds for US approval of novel pacemaker leads
Health & Biotech
Scott Power: Telix achieves sustained growth; Pro Medicus wins another contract
Stockhead TV
Tony’s Takeaway: New year nuggets for biotech-hungry investors
Health & Biotech
First paediatric patient recruited for Dimerix’s ACTION3 kidney disease drug trial
Health & Biotech
Health Check: Pro Medicus lands $33m deal; RoXsta antioxidant profiling shows potential
Health & Biotech
Health Check: Biotech partnership eyes Euro market expansion for Rett syndrome drug
Health & Biotech
Vital Signs Podcast: Aroa Biosurgery’s difference-making diagnosis
News
Skin in the game: Why investing in founder-led companies can pay off
Health & Biotech
Health Check: Mesoblast shares sink despite $260m placement and FDA win
Load More